Literature DB >> 15986869

A clinical-morphological study on cholestatic presentation of nonalcoholic fatty liver disease.

P Sorrentino1, G Tarantino, A Perrella, P Micheli, O Perrella, P Conca.   

Abstract

To determine the association among the clinical, biochemical, and histological features of cholestasis, we analyzed all the relevant data of the patients recorded in our non-alcoholic fatty liver disease (NAFLD) database. We selected 20 NAFLD patients with abnormal transaminase levels, with both alkaline phosphatase >500 U/L and gamma-glutamyl transpeptidase >250 U/L. Their histological features were compared with those of a group of patients with NAFLD matched for sex, age, and body mass index and of a group of patients matched for sex, body mass index and histological NAFLD grading/staging. Cases and controls satisfied, on histology, the criteria for NASH. The presence of cholestasis in our patients was correlated with injury of the bile duct epithelium, characterized by cholangitis, swelling, variable bile duct loss, and bile stasis. Compared to NAFLD patients of similar age, sex, and body mass index, the cholestatic group had total and severe histological liver impairment. When we analyzed the group of patients histologically identified on the basis of identical stage and grade severity, we could not find any evidence of significant bile damage, compared to cases, despite the control group's significantly older age. NAFLD patients with biochemical cholestasis have a histological picture of bile damage; they have more advanced histological impairment than patients matched for age, sex and body mass index.

Entities:  

Mesh:

Year:  2005        PMID: 15986869     DOI: 10.1007/s10620-005-2719-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  44 in total

1.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

Authors:  J B Dixon; P S Bhathal; P E O'Brien
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

Review 2.  Review article: hepatobiliary complications associated with total parenteral nutrition.

Authors:  M Angelico; P Della Guardia
Journal:  Aliment Pharmacol Ther       Date:  2000-05       Impact factor: 8.171

3.  Nonalcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler.

Authors:  R G Lee
Journal:  Hepatology       Date:  1995-06       Impact factor: 17.425

4.  Steatosis, cholestasis, and alkaline phosphatase in alcoholic liver disease.

Authors:  D B McGill
Journal:  Am J Dig Dis       Date:  1978-12

5.  Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.

Authors:  A Poonawala; S P Nair; P J Thuluvath
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

Review 7.  [Hepatic diseases caused by drugs].

Authors:  F Lammert; S Matern
Journal:  Praxis (Bern 1994)       Date:  1997-07-16

8.  Cholestasis in acute alcoholic liver disease.

Authors:  S C Glover; J L McPhie; P W Brunt
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

9.  Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease?

Authors:  P Beau; J Labat-Labourdette; P Ingrand; M Beauchant
Journal:  J Hepatol       Date:  1994-02       Impact factor: 25.083

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  15 in total

1.  Saturated free fatty acids induce cholangiocyte lipoapoptosis.

Authors:  Sathish Kumar Natarajan; Sally A Ingham; Ashley M Mohr; Cody J Wehrkamp; Anuttoma Ray; Sohini Roy; Sophie C Cazanave; Mary Anne Phillippi; Justin L Mott
Journal:  Hepatology       Date:  2014-06-20       Impact factor: 17.425

2.  Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH).

Authors:  Z Wang; Z Zhao; Y Xia; Z Cai; C Wang; Y Shen; R Liu; H Qin; J Jia; G Yuan
Journal:  J Endocrinol Invest       Date:  2022-02-28       Impact factor: 4.256

3.  Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice.

Authors:  Maxwell Afari Gyamfi; Yuji Tanaka; Lin He; Curtis D Klaassen; Yu-Jui Yvonne Wan
Journal:  Toxicol Appl Pharmacol       Date:  2008-10-08       Impact factor: 4.219

Review 4.  Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

Authors:  James J Beaudoin; Kim L R Brouwer; Melina M Malinen
Journal:  Pharmacol Ther       Date:  2020-04-02       Impact factor: 12.310

5.  The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury.

Authors:  Maxwell Afari Gyamfi; Ivan Damjanov; Samuel French; Yu-Jui Yvonne Wan
Journal:  Biochem Pharmacol       Date:  2007-10-18       Impact factor: 5.858

6.  Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet.

Authors:  Bo Kong; James P Luyendyk; Ossama Tawfik; Grace L Guo
Journal:  J Pharmacol Exp Ther       Date:  2008-10-23       Impact factor: 4.030

7.  Defining hepatic dysfunction parameters in two models of fatty liver disease in zebrafish larvae.

Authors:  Deanna L Howarth; Chunyue Yin; Karen Yeh; Kirsten C Sadler
Journal:  Zebrafish       Date:  2013-05-22       Impact factor: 1.985

8.  Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling.

Authors:  Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Jennifer M Bailey; Wasim Dar; Kishore Polireddy; Qingzheng Chen; Moises I Nevah Rubin; Amelia Sybenga; Sharon DeMorrow; Fanyin Meng; Lindsey Stockton; Gianfranco Alpini; Heather Francis
Journal:  Am J Pathol       Date:  2017-12-15       Impact factor: 4.307

9.  A study of standardized extracts of Picrorhiza kurroa Royle ex Benth in experimental nonalcoholic fatty liver disease.

Authors:  Sapna N Shetty; Sushma Mengi; Rama Vaidya; Ashok D B Vaidya
Journal:  J Ayurveda Integr Med       Date:  2010-07

10.  Circadian dysregulation disrupts bile acid homeostasis.

Authors:  Ke Ma; Rui Xiao; Hsiu-Ting Tseng; Lu Shan; Loning Fu; David D Moore
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.